Header Logo

DANIEL AYANGA

Concepts (11)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Adrenergic alpha-2 Receptor Agonists
1
2016
27
0.510
 Why?
Opiate Substitution Treatment
1
2016
33
0.510
 Why?
Narcotic Antagonists
1
2016
112
0.490
 Why?
Buprenorphine
1
2016
103
0.480
 Why?
Opioid-Related Disorders
1
2016
285
0.410
 Why?
Clonidine
1
2016
37
0.130
 Why?
Naltrexone
1
2016
70
0.130
 Why?
Methadone
1
2016
126
0.120
 Why?
Combined Modality Therapy
1
2016
1312
0.100
 Why?
Treatment Outcome
1
2016
13105
0.040
 Why?
Humans
1
2016
134225
0.010
 Why?
AYANGA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (11)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_